Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
2,694,940
-
Share change
-
-706
-
Total reported value
-
$35,802,000
-
Price per share
-
$13.28
-
Number of holders
-
15
-
Value change
-
-$9,122
-
Number of buys
-
7
-
Number of sells
-
4
Institutional Holders of SUMMIT THERAPEUTICS INC COM - Stock (SMMT) as of Q1 2017
As of 31 Mar 2017,
SUMMIT THERAPEUTICS INC COM - Stock (SMMT) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,694,940 shares.
The largest 10 holders included
LANSDOWNE PARTNERS (UK) LLP, Point72 Asset Management, L.P., AXA, First Eagle Investment Management, LLC, SPHERA FUNDS MANAGEMENT LTD., Granite Point Capital Management, L.P., Knoll Capital Management, LP, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.